Scarica l'app Stockscreener
1.325
1.92%
0.025
Precedente Chiudi:
$1.30
Aprire:
$1.27
Volume 24 ore:
91,325
Relative Volume:
0.22
Capitalizzazione di mercato:
$41.52M
Reddito:
-
Utile/perdita netta:
$-69.00M
Rapporto P/E:
-0.4766
EPS:
-2.78
Flusso di cassa netto:
$-55.26M
1 W Prestazione:
-4.68%
1M Prestazione:
-5.36%
6M Prestazione:
-76.08%
1 anno Prestazione:
-85.58%
Intervallo 1D:
$1.27
$1.34
Intervallo di 1 settimana:
$1.27
$1.435
Portata 52W:
$1.05
$10.16
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
Nome
Acrivon Therapeutics Inc
Settore
Industria
Telefono
617-207-8979
Indirizzo
480 ARSENAL WAY, SUITE 100, WATERTOWN
Confronta ACRV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.32 | 43.72M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.93 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.13 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.86 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.12 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.95 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-05 | Ripresa | Piper Sandler | Overweight |
| 2025-01-31 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-12-15 | Ripresa | Jefferies | Buy |
| 2023-10-05 | Iniziato | Maxim Group | Buy |
| 2023-06-02 | Iniziato | Oppenheimer | Outperform |
| 2023-05-08 | Iniziato | BMO Capital Markets | Outperform |
| 2023-04-27 | Iniziato | Ladenburg Thalmann | Buy |
| 2023-04-20 | Iniziato | H.C. Wainwright | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-12-12 | Iniziato | Jefferies | Buy |
| 2022-12-12 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Acrivon Therapeutics Inc Borsa (ACRV) Ultime notizie
Is this a good reentry point in Acrivon Therapeutics Inc.Market Sentiment Report & Free Growth Oriented Trading Recommendations - Newser
Acrivon Therapeutics Inc. Recovery Likely Here’s What Data ShowsPortfolio Performance Report & High Win Rate Trade Tips - kangso.co.kr
Price Action Confirms Reversal in Acrivon Therapeutics Inc. TrendWeekly Stock Analysis & Consistent Income Trade Recommendations - classian.co.kr
ACR-368 OncoSignature assay gains FDA breakthrough status - MSN
Is Acrivon Therapeutics Inc. stock a good hedge against inflation2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Using fundamentals and technicals on Acrivon Therapeutics Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Acrivon Therapeutics Inc. stock chart pattern explained2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Real time breakdown of Acrivon Therapeutics Inc. stock performance2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
What indicators show strength in Acrivon Therapeutics Inc.July 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Acrivon Therapeutics Inc. stock prediction for this weekMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Visual analytics tools that track Acrivon Therapeutics Inc. performanceJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser
Smart tools for monitoring Acrivon Therapeutics Inc.’s price actionWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Full technical analysis of Acrivon Therapeutics Inc. stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
What does recent volatility data suggest for Acrivon Therapeutics Inc.Earnings Trend Report & Expert Approved Momentum Ideas - Newser
Why Acrivon Therapeutics Inc. is moving todayRecession Risk & Weekly High Potential Stock Alerts - Newser
How to recover losses in Acrivon Therapeutics Inc. stockEarnings Summary Report & Consistent Income Trade Recommendations - Newser
How institutional ownership impacts Acrivon Therapeutics Inc. stockQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Can volume confirm reversal in Acrivon Therapeutics Inc.July 2025 Patterns & Risk Controlled Swing Alerts - Newser
Understanding Acrivon Therapeutics Inc.’s price movementJuly 2025 Action & Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-19 01:37:39 - Newser
Best data tools to analyze Acrivon Therapeutics Inc. stockWeekly Risk Report & Consistent Income Trade Ideas - Newser
Relative strength of Acrivon Therapeutics Inc. in sector analysisTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Acrivon Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
Acrivon Therapeutics’ SWOT analysis: precision medicine stock faces pivotal trials - Investing.com
Research Analysts Set Expectations for ACRV Q3 Earnings - Defense World
Momentum divergence signals in Acrivon Therapeutics Inc. chartWeekly Trade Review & High Win Rate Trade Alerts - Newser
Is Acrivon Therapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - Newser
Is Acrivon Therapeutics Inc. forming a double bottomQuarterly Performance Summary & Low Risk Entry Point Tips - 선데이타임즈
Historical volatility pattern of Acrivon Therapeutics Inc. visualizedOil Prices & Free Technical Pattern Based Buy Signals - Newser
Is Acrivon Therapeutics Inc. a potential multi baggerDip Buying & Technical Pattern Recognition Alerts - thegnnews.com
Is Acrivon Therapeutics Inc. stock a smart retirement pick2025 Price Targets & Weekly Momentum Stock Picks - newsyoung.net
Acrivon Therapeutics, Inc.: Promising Clinical Developments and Strong Financial Position Justify Buy Rating - TipRanks
Detecting support and resistance levels for Acrivon Therapeutics Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Real time alert setup for Acrivon Therapeutics Inc. performanceMarket Volume Summary & Technical Pattern Alert System - Newser
Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionWatch List & Weekly Momentum Picks - Newser
Short interest data insights for Acrivon Therapeutics Inc.Fed Meeting & Real-Time Buy Signal Alerts - Newser
Acrivon Therapeutics Inc Azioni (ACRV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Acrivon Therapeutics Inc Azioni (ACRV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
1.33%
0.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):